With support from Agilent Technologies, MGH researcher Robert Gerszten, MD, is tracking blood changes to help predict who needs early treatment for heart disease and diabetes.
Biogen Foundation and the Cleary family have committed nearly half the funds needed to establish an endowed chair honoring former Neurology Chief Anne B. Young, MD, PhD.
Stand Up To Cancer and the American Cancer Society are funding a 3-year effort to combine the powers of targeted therapies with immunotherapies against a deadly form of lung cancer.
Elizabeth Thiele, MD, PhD, a world-renowned expert on tuberous sclerosis complex, says remarkable progress is being made in helping those with the disorder.
Mass General’s Diabetes Prevention Program made a big difference for one brother facing the very dangerous disease.
A Mass General addiction expert says one police department’s emphasis on treatment over arrest is an encouraging step in addressing the drug epidemic.
To design an effective HIV vaccine, Mass General researcher Todd Allen, PhD, is focused on understanding how HIV evades the body’s immune system defenses.
Through its Center for Community Health Improvement, Mass General collaborates with local communities to create better environments and healthier choices.
Hunting the causes of brain degeneration is leading neuroscientists to exciting new possible therapies to help patients with Parkinson’s disease and ALS.
A Mass General cholera specialist and the Madison family join forces against cholera and other child-killing diarrheal diseases in Haiti.